ZA200302671B - A kit for detecting non-pathogenic or pathogenic influenza A subtype H5 virus. - Google Patents
A kit for detecting non-pathogenic or pathogenic influenza A subtype H5 virus. Download PDFInfo
- Publication number
- ZA200302671B ZA200302671B ZA200302671A ZA200302671A ZA200302671B ZA 200302671 B ZA200302671 B ZA 200302671B ZA 200302671 A ZA200302671 A ZA 200302671A ZA 200302671 A ZA200302671 A ZA 200302671A ZA 200302671 B ZA200302671 B ZA 200302671B
- Authority
- ZA
- South Africa
- Prior art keywords
- dna
- virus
- molecule
- purified
- pathogenic
- Prior art date
Links
- 241000700605 Viruses Species 0.000 title claims abstract description 130
- 230000001717 pathogenic effect Effects 0.000 title claims abstract description 77
- 208000037797 influenza A Diseases 0.000 title claims abstract description 55
- 238000001514 detection method Methods 0.000 claims abstract description 118
- 102000004190 Enzymes Human genes 0.000 claims abstract description 16
- 108090000790 Enzymes Proteins 0.000 claims abstract description 16
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 201
- 108020004414 DNA Proteins 0.000 claims description 90
- 150000007523 nucleic acids Chemical class 0.000 claims description 71
- 102000053602 DNA Human genes 0.000 claims description 69
- 102000039446 nucleic acids Human genes 0.000 claims description 49
- 108020004707 nucleic acids Proteins 0.000 claims description 49
- 239000003795 chemical substances by application Substances 0.000 claims description 38
- 239000012472 biological sample Substances 0.000 claims description 35
- 230000000295 complement effect Effects 0.000 claims description 30
- 239000002773 nucleotide Substances 0.000 claims description 24
- 125000003729 nucleotide group Chemical group 0.000 claims description 24
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 claims description 18
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 claims description 18
- 238000004519 manufacturing process Methods 0.000 claims description 17
- 108020004635 Complementary DNA Proteins 0.000 claims description 16
- 238000010804 cDNA synthesis Methods 0.000 claims description 16
- 239000002299 complementary DNA Substances 0.000 claims description 16
- 230000003362 replicative effect Effects 0.000 claims description 13
- 230000009089 cytolysis Effects 0.000 claims description 8
- 101000686777 Escherichia phage T7 T7 RNA polymerase Proteins 0.000 claims description 4
- 230000000087 stabilizing effect Effects 0.000 claims 2
- 241000701832 Enterobacteria phage T3 Species 0.000 claims 1
- 239000000523 sample Substances 0.000 abstract description 34
- 108020000999 Viral RNA Proteins 0.000 abstract description 23
- 238000000034 method Methods 0.000 abstract description 23
- 230000035945 sensitivity Effects 0.000 abstract description 5
- 238000010240 RT-PCR analysis Methods 0.000 abstract description 3
- 238000003018 immunoassay Methods 0.000 abstract description 3
- 238000004113 cell culture Methods 0.000 abstract description 2
- 230000003100 immobilizing effect Effects 0.000 abstract 1
- 230000010076 replication Effects 0.000 abstract 1
- 229920002477 rna polymer Polymers 0.000 description 53
- 230000003321 amplification Effects 0.000 description 27
- 238000003199 nucleic acid amplification method Methods 0.000 description 27
- 239000000243 solution Substances 0.000 description 24
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 23
- 108090000623 proteins and genes Proteins 0.000 description 20
- 239000003153 chemical reaction reagent Substances 0.000 description 19
- 239000012139 lysis buffer Substances 0.000 description 19
- 239000000203 mixture Substances 0.000 description 16
- 238000012360 testing method Methods 0.000 description 12
- 238000009396 hybridization Methods 0.000 description 10
- 239000000377 silicon dioxide Substances 0.000 description 10
- 230000003612 virological effect Effects 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 238000002955 isolation Methods 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 239000011534 wash buffer Substances 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 239000007983 Tris buffer Substances 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 241000271566 Aves Species 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 101710137500 T7 RNA polymerase Proteins 0.000 description 4
- 238000003556 assay Methods 0.000 description 4
- 239000011324 bead Substances 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- ZJYYHGLJYGJLLN-UHFFFAOYSA-N guanidinium thiocyanate Chemical compound SC#N.NC(N)=N ZJYYHGLJYGJLLN-UHFFFAOYSA-N 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000008188 pellet Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 241000712461 unidentified influenza virus Species 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 102100034343 Integrase Human genes 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 238000000137 annealing Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 206010022000 influenza Diseases 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 241000287828 Gallus gallus Species 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 241000712431 Influenza A virus Species 0.000 description 2
- 208000002979 Influenza in Birds Diseases 0.000 description 2
- 101710203526 Integrase Proteins 0.000 description 2
- 108700005077 Viral Genes Proteins 0.000 description 2
- 239000002390 adhesive tape Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 206010064097 avian influenza Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- VXIVSQZSERGHQP-UHFFFAOYSA-N chloroacetamide Chemical compound NC(=O)CCl VXIVSQZSERGHQP-UHFFFAOYSA-N 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 239000012149 elution buffer Substances 0.000 description 2
- -1 for example Substances 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 230000005298 paramagnetic effect Effects 0.000 description 2
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- GWOGSJALVLHACY-UHFFFAOYSA-N 2-pyridin-2-ylpyridine;ruthenium Chemical compound [Ru].N1=CC=CC=C1C1=CC=CC=N1 GWOGSJALVLHACY-UHFFFAOYSA-N 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 108091093088 Amplicon Proteins 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 description 1
- 238000009007 Diagnostic Kit Methods 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- 108060001084 Luciferase Proteins 0.000 description 1
- 239000005089 Luciferase Substances 0.000 description 1
- DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 239000012131 assay buffer Substances 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000009260 cross reactivity Effects 0.000 description 1
- 230000005574 cross-species transmission Effects 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- FFYPMLJYZAEMQB-UHFFFAOYSA-N diethyl pyrocarbonate Chemical compound CCOC(=O)OC(=O)OCC FFYPMLJYZAEMQB-UHFFFAOYSA-N 0.000 description 1
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000006249 magnetic particle Substances 0.000 description 1
- 238000009595 pap smear Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000007918 pathogenicity Effects 0.000 description 1
- 210000005105 peripheral blood lymphocyte Anatomy 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 239000012088 reference solution Substances 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000003260 vortexing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/582—Recycling of unreacted starting or intermediate materials
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN00106310 | 2000-10-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200302671B true ZA200302671B (en) | 2004-02-27 |
Family
ID=4578275
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200302671A ZA200302671B (en) | 2000-10-05 | 2003-04-04 | A kit for detecting non-pathogenic or pathogenic influenza A subtype H5 virus. |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US7611837B2 (zh) |
| EP (1) | EP1330553B1 (zh) |
| JP (2) | JP2004509648A (zh) |
| KR (1) | KR100937761B1 (zh) |
| CN (1) | CN1258604C (zh) |
| AT (1) | ATE435305T1 (zh) |
| AU (2) | AU2002214936B2 (zh) |
| BR (1) | BR0114468A (zh) |
| CA (2) | CA2424867C (zh) |
| DE (1) | DE60139136D1 (zh) |
| HK (1) | HK1057768A1 (zh) |
| MX (1) | MXPA03002995A (zh) |
| NZ (1) | NZ525190A (zh) |
| WO (1) | WO2002029118A1 (zh) |
| ZA (1) | ZA200302671B (zh) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1310565B1 (en) * | 2001-11-09 | 2008-01-09 | Hong Kong DNA Chips Limited | A process for detecting nucleic acid target molecules using an enzyme-linked probe capture assay and a kit therefor |
| GB2401175A (en) * | 2003-05-02 | 2004-11-03 | Hong Kong Dna Chips Ltd | Detection of SARS virus by PCR |
| WO2005121367A1 (en) * | 2004-06-10 | 2005-12-22 | Agency For Science, Technology And Research | Diagnostic primers and method for detecting avian influenza virus subtype h5 and h5n1 |
| CN101052720B (zh) * | 2004-11-01 | 2012-12-26 | 荣研化学株式会社 | H5型或h7型禽流感病毒的检测方法 |
| WO2006049061A1 (ja) * | 2004-11-01 | 2006-05-11 | Eiken Kagaku Kabushiki Kaisha | Ｈ５型又はｈ７型トリインフルエンザウイルスの検出方法 |
| AU2006244460B2 (en) * | 2005-05-06 | 2010-04-08 | Gen-Probe Incorporated | Compositions and assays to detect influenza virus A and B nucleic acids |
| KR100796007B1 (ko) | 2005-08-19 | 2008-01-21 | 대한민국 | 인플루엔자 바이러스 검출용 프라이머, 이를 이용한검출방법 및 검출키트 |
| GB2432419A (en) * | 2005-11-16 | 2007-05-23 | Agency Science Tech & Res | Influenza A virus detection method |
| FR2902430B1 (fr) * | 2005-11-25 | 2012-11-02 | Biomerieux Sa | Oligonucleotides, utilisation, methode de detection et kit permettant de diagnostiquer la presence des genes h5 et n1 du virus d'influenza a |
| JP5351418B2 (ja) * | 2005-12-26 | 2013-11-27 | 株式会社ビーエル | Ａ型インフルエンザウイルスｈ５亜型の検出法 |
| WO2007074811A1 (ja) | 2005-12-26 | 2007-07-05 | Bl Co., Ltd. | Ａ型インフルエンザウイルス強毒株の検出法 |
| CA3031887C (en) | 2006-02-13 | 2023-02-07 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention | Primers and probes for detection and discrimination of types and subtypes of influenza viruses |
| CN100465616C (zh) * | 2006-03-10 | 2009-03-04 | 厦门大学 | 活菌微量检测方法 |
| WO2008000023A1 (en) * | 2006-06-26 | 2008-01-03 | Biochip Innovations Pty Ltd | Detection of influenza virus |
| US20090098527A1 (en) * | 2006-09-12 | 2009-04-16 | Fischer Gerald W | Biological organism identification product and methods |
| US8080645B2 (en) | 2007-10-01 | 2011-12-20 | Longhorn Vaccines & Diagnostics Llc | Biological specimen collection/transport compositions and methods |
| US8652782B2 (en) | 2006-09-12 | 2014-02-18 | Longhorn Vaccines & Diagnostics, Llc | Compositions and methods for detecting, identifying and quantitating mycobacterial-specific nucleic acids |
| US8097419B2 (en) | 2006-09-12 | 2012-01-17 | Longhorn Vaccines & Diagnostics Llc | Compositions and method for rapid, real-time detection of influenza A virus (H1N1) swine 2009 |
| US9481912B2 (en) | 2006-09-12 | 2016-11-01 | Longhorn Vaccines And Diagnostics, Llc | Compositions and methods for detecting and identifying nucleic acid sequences in biological samples |
| US9683256B2 (en) | 2007-10-01 | 2017-06-20 | Longhorn Vaccines And Diagnostics, Llc | Biological specimen collection and transport system |
| US11041215B2 (en) | 2007-08-24 | 2021-06-22 | Longhorn Vaccines And Diagnostics, Llc | PCR ready compositions and methods for detecting and identifying nucleic acid sequences |
| CA2697373C (en) | 2007-08-27 | 2019-05-21 | Longhorn Vaccines & Diagnostics, Llc | Immunogenic compositions and methods |
| US10004799B2 (en) | 2007-08-27 | 2018-06-26 | Longhorn Vaccines And Diagnostics, Llc | Composite antigenic sequences and vaccines |
| US11041216B2 (en) | 2007-10-01 | 2021-06-22 | Longhorn Vaccines And Diagnostics, Llc | Compositions and methods for detecting and quantifying nucleic acid sequences in blood samples |
| WO2009085355A2 (en) | 2007-10-01 | 2009-07-09 | Longhorn Vaccines & Diagnostics Llc | Biological specimen collection and transport system and methods of use |
| US20100143890A1 (en) * | 2008-12-08 | 2010-06-10 | Electronics And Telecommunications Research Institute | Peptide compounds for capturing or inhibiting avian influenza virus and application thereof |
| CN101603096A (zh) * | 2009-05-04 | 2009-12-16 | 北京海康基因芯片开发有限公司 | 一种检测传染病病原体的方法及试剂盒 |
| CN101545010B (zh) * | 2009-05-11 | 2014-07-16 | 海康生命科技有限公司 | 一种检测传染病病原体的方法及试剂盒 |
| CN101545014B (zh) * | 2009-05-11 | 2014-07-16 | 海康生命科技有限公司 | 一种检测传染病病原体的方法及试剂盒 |
| KR101341640B1 (ko) * | 2010-02-05 | 2013-12-16 | 한국전자통신연구원 | 단백질 미세 구조 분석 방법 및 단백질 미세 구조 분석용 어레이 |
| CA2863083C (en) | 2012-01-26 | 2023-09-19 | Longhorn Vaccines And Diagnostics, Llc | Composite antigenic sequences and vaccines |
| CN104694541A (zh) * | 2013-12-09 | 2015-06-10 | 江苏命码生物科技有限公司 | 禽流感病毒miRNA及其鉴定、检测和应用 |
| EP3294448A4 (en) | 2015-05-14 | 2018-12-12 | Longhorn Vaccines and Diagnostics, LLC | Rapid methods for the extraction of nucleic acids from biological samples |
| TWI766942B (zh) * | 2017-02-13 | 2022-06-11 | 美商海科生醫有限責任公司 | 透過利用瞬態和穩態間隔振動移液管來混合流體或介質的設備和方法 |
| WO2021058145A1 (en) * | 2019-09-24 | 2021-04-01 | Max-Delbrück-Centrum Für Molekulare Medizin In Der Helmholtz-Gemeinschaft | Phage t7 promoters for boosting in vitro transcription |
| KR102512759B1 (ko) * | 2020-06-02 | 2023-03-23 | 주식회사 셀앤바이오 | 재사용 가능한 바이러스 신속 검출용 dna 바이오 센서 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5622820A (en) * | 1988-03-10 | 1997-04-22 | City Of Hope | Method for amplification and detection of RNA and DNA sequences |
| DE4344742A1 (de) * | 1993-06-09 | 1994-12-15 | Boehringer Mannheim Gmbh | Verfahren zur Immobilisierung von Nukleinsäuren |
| US5582978A (en) | 1994-01-21 | 1996-12-10 | Amoco Corporation | Nucleic acid probes for the detection of Haemophilus influenzae |
| US5660989A (en) | 1995-06-07 | 1997-08-26 | Merck & Co., Inc. | DNA polymerase extension assay for influenza virus endonuclease |
| WO2000000638A2 (en) * | 1998-06-26 | 2000-01-06 | Akzo Nobel N.V. | Tagging of rna amplicons generated by transcription-based amplification |
| ATE405674T1 (de) | 1998-09-24 | 2008-09-15 | Innogenetics Nv | Identizierung von microorganismen,die akute atemwegsinfektionen verursachen |
-
2001
- 2001-09-27 EP EP01983425A patent/EP1330553B1/en not_active Expired - Lifetime
- 2001-09-27 CA CA2424867A patent/CA2424867C/en not_active Expired - Fee Related
- 2001-09-27 CN CNB018192939A patent/CN1258604C/zh not_active Expired - Fee Related
- 2001-09-27 KR KR1020037004883A patent/KR100937761B1/ko not_active IP Right Cessation
- 2001-09-27 BR BR0114468-5A patent/BR0114468A/pt not_active IP Right Cessation
- 2001-09-27 US US10/398,207 patent/US7611837B2/en not_active Expired - Fee Related
- 2001-09-27 CA CA2802193A patent/CA2802193A1/en not_active Abandoned
- 2001-09-27 AU AU2002214936A patent/AU2002214936B2/en not_active Ceased
- 2001-09-27 NZ NZ525190A patent/NZ525190A/en not_active IP Right Cessation
- 2001-09-27 DE DE60139136T patent/DE60139136D1/de not_active Expired - Lifetime
- 2001-09-27 WO PCT/CN2001/001458 patent/WO2002029118A1/en active IP Right Grant
- 2001-09-27 MX MXPA03002995A patent/MXPA03002995A/es active IP Right Grant
- 2001-09-27 AT AT01983425T patent/ATE435305T1/de not_active IP Right Cessation
- 2001-09-27 AU AU1493602A patent/AU1493602A/xx active Pending
- 2001-09-27 JP JP2002532686A patent/JP2004509648A/ja active Pending
-
2003
- 2003-04-04 ZA ZA200302671A patent/ZA200302671B/en unknown
-
2004
- 2004-01-29 HK HK04100619.7A patent/HK1057768A1/xx not_active IP Right Cessation
-
2009
- 2009-10-05 US US12/573,855 patent/US20100112548A1/en not_active Abandoned
-
2012
- 2012-06-14 JP JP2012134653A patent/JP2012191943A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN1476485A (zh) | 2004-02-18 |
| CN1258604C (zh) | 2006-06-07 |
| CA2802193A1 (en) | 2002-04-11 |
| CA2424867A1 (en) | 2002-04-11 |
| US7611837B2 (en) | 2009-11-03 |
| ATE435305T1 (de) | 2009-07-15 |
| AU2002214936B2 (en) | 2007-07-19 |
| EP1330553A4 (en) | 2004-12-08 |
| DE60139136D1 (de) | 2009-08-13 |
| WO2002029118A1 (en) | 2002-04-11 |
| US20100112548A1 (en) | 2010-05-06 |
| JP2004509648A (ja) | 2004-04-02 |
| EP1330553A1 (en) | 2003-07-30 |
| EP1330553B1 (en) | 2009-07-01 |
| NZ525190A (en) | 2004-02-27 |
| KR20030045106A (ko) | 2003-06-09 |
| CA2424867C (en) | 2013-03-26 |
| AU1493602A (en) | 2002-04-15 |
| HK1057768A1 (en) | 2004-04-16 |
| US20040142319A1 (en) | 2004-07-22 |
| BR0114468A (pt) | 2005-01-11 |
| MXPA03002995A (es) | 2004-12-06 |
| JP2012191943A (ja) | 2012-10-11 |
| KR100937761B1 (ko) | 2010-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7611837B2 (en) | Kit for detecting non-pathogenic or pathogenic influenza a subtype h5 virus | |
| AU2002214936A1 (en) | A kit for detecting non-pathogenic or pathogenic influenza a subtype H5 virus | |
| Collins et al. | Detection of highly pathogenic and low pathogenic avian influenza subtype H5 (Eurasian lineage) using NASBA | |
| CN110551846B (zh) | 一种用于非洲猪瘟病毒核酸快速检测的Cpf1试剂盒及其检测方法 | |
| Heddema et al. | Prevalence of Chlamydophila psittaci in fecal droppings from feral pigeons in Amsterdam, The Netherlands | |
| CN111778357A (zh) | 基于CRISPR/Cas12a的呼吸道合胞病毒核酸快速检测试剂盒及其检测方法 | |
| US20080261198A1 (en) | Diagnostic Primers and Method for Detecting Avian Influenza Virus Subtype H5 and H5n1 | |
| US5744299A (en) | Human parainfluenza virus-1 assay | |
| Roy et al. | Diverse molecular techniques for early diagnosis of COVID-19 and other coronaviruses | |
| CN113637806A (zh) | 一种用于口蹄疫病毒检测的试剂盒及其检测方法 | |
| JP2020533974A (ja) | 呼吸器合胞体ウイルス種のニッキング及び伸長増幅反応（ｎｅａｒ） | |
| TW201245452A (en) | Nucleic acid detection | |
| US20210340635A1 (en) | Materials and methods for detecting coronavirus | |
| WO2006132601A1 (en) | Diagnostic primers and method for detecting avian influenza virus subtype h5 and h5n1 | |
| EP1308521B1 (en) | A process and a kit for detecting foot-and-mouth disease virus | |
| KR100399715B1 (ko) | Cmv핵산증폭 및 검출용 프라이머와 프로브 | |
| EP1310565A1 (en) | A process for detecting nucleic acid target molecules using an enzyme-linked probe capture assay and a kit therefor | |
| Liu et al. | Comparison of two molecular techniques for the detection of avian reoviruses in formalin-fixed, paraffin-embedded chicken tissues | |
| Delgado et al. | Efficiency of automated viral RNA purification for pediatric studies of dengue and zika in hyperendemic areas | |
| KR101256984B1 (ko) | Ｒｔ－ｐｃｒ ｅｌｉｓａ를 이용한 ｅ형 간염 바이러스 검출방법 및 키트 | |
| CN113341146B (zh) | 用于检测乙肝病毒的比色传感器及其制备与应用 | |
| CN106755546B (zh) | 一种鹿中结核分枝杆菌nasba-elisa快速检测试剂盒及检测方法 | |
| CN103866045B (zh) | Hav检测 | |
| AU6728298A (en) | Oligonucleotides that can be used in the amplification and detection of cmv nucleic acid | |
| Muir et al. | One-Day Detection of Enteroviruses in Clinical Specimens by Magnetic Bead Extraction of Viral RNA and Nested Polymerase Chain Reaction |